People
McKenzie Cato's expertise is assisting medical device, pharmaceutical, and food and beverage companies with pre- and post-market regulatory topics. McKenzie helps companies in developing their FDA regulatory strategy, preparing regulatory submissions, responding to FDA requests for information and data, drafting regulatory policies and procedures, and reviewing advertising and promotional materials. McKenzie also assists companies with FDA, DOJ, and DEA enforcement matters, regulatory due diligence, and state regulatory and licensing issues.
Juris Doctor, George Washington University Law School, honors
B.S. Chemistry, Georgetown University
District of Columbia
Pennsylvania
January 9, 2026
FDA Updates General Wellness and Clinical Decision Support Guidance Documents
December 19, 2025
President Trump Signs Executive Order to Reschedule Marijuana, Easing Research and Business Restrictions
June 12, 2025
5 Open Questions About FDA's AI-Assisted Review Plans
January 9, 2026
FDA Updates General Wellness and Clinical Decision Support Guidance Documents
December 19, 2025
President Trump Signs Executive Order to Reschedule Marijuana, Easing Research and Business Restrictions
June 12, 2025
5 Open Questions About FDA's AI-Assisted Review Plans
Juris Doctor, George Washington University Law School, honors
B.S. Chemistry, Georgetown University
District of Columbia
Pennsylvania